Agilent Technologies Inc: (NYSE: A)

$45.99

2.02 (4.59%)

Volume 3,690,081

May 15 10:39 AM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Full Company Report

Get Full Company Report for:

Agilent Technologies is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. Agilent has two primary business segments: Bio-Analytical Measurement and Electronic Measurement.

General Information

AGILENT TECH
5301 STEVENS CREEK BLVD
SANTA CLARA, CA 95052-8059
Phone: 408-345-8296
Fax: 408-345-8474
Web: http://www.home.agilent.com
Email: investor_relations@agilent.com

Industry ELEC TEST EQUIPTMENT
Sector Computer and Technology
Fiscal Year End October
Last Reported Quarter 04/30/2013
Next EPS Date 08/14/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 43.97
52 Week High 46.49
52 Week Low 35.32
Beta 1.52
20 Day Moving Average 3,489,222.00
Target Price Consensus 48.83

% Price Change

4 Week 1.34
12 Week 2.23
YTD 5.13

Share Information

Shares Outstanding (millions) 347.16
Market Capitalization (millions) 15,264.58
Short Ratio 0.82
Last Split Date NA

A

% Price Change Relative to S&P 500

4 Week -3.32
12 Week -5.16
YTD -6.97

Dividend Information

Dividend Yield 1.09%
Annual Dividend $0.48
Payout Ratio 0.13
Change in Payout Ratio NA
Last Dividend Payout / Amount 03/28/2013 / $0.12

EPS Information

Current Quarter EPS Consensus Estimate 0.75
Current Year EPS Consensus Estimate 2.88
Estimated Long-Term EPS Growth Rate 10.40
Next EPS Report Date 08/14/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 1.11
30 Days Ago 1.11
60 Days Ago 1.11
90 Days Ago 1.12

Fundamental Ratios

P/E

Current FY Estimate 15.26
Trailing 12 Months 14.51
PEG Ratio 1.47

Price Ratios

Price/Book 2.86
Price/Cash Flow 10.94
Price / Sales 2.21

Current Ratio

04-30-13 NA
01-31-13 2.55
10-31-12 2.45

Net Margin

04-30-13 NA
01-31-13 15.96
10-31-12 16.81

Inventory Turnover

04-30-13 NA
01-31-13 3.26
10-31-12 3.31

EPS Growth

vs. Previous Year -8.70%
vs. Previous Quarter -25.00%
   

ROE

04-30-13 NA
01-31-13 21.41
10-31-12 22.82

Quick Ratio

04-30-13 NA
01-31-13 1.99
10-31-12 1.91

Pre-Tax Margin

04-30-13 NA
01-31-13 14.23
10-31-12 15.21

Debt-to-Equity

04-30-13 NA
01-31-13 0.39
10-31-12 0.41

Sales Growth

vs. Previous Year 2.75%
vs. Previous Quarter -4.92%
   

ROA

04-30-13 NA
01-31-13 10.68
10-31-12 11.34

Operating Margin

04-30-13 NA
01-31-13 15.61
10-31-12 16.04

Book Value

04-30-13 NA
01-31-13 15.38
10-31-12 14.88

Debt to Capital

04-30-13 NA
01-31-13 28.29
10-31-12 28.94

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.